Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$397.50 USD

397.50
1,388,392

-5.93 (-1.47%)

Updated Sep 17, 2024 04:00 PM ET

After-Market: $397.50 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 251)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Community Health (CYH) Soars 168.6% YTD: More Room to Run?

by Zacks Equity Research

Community Health's (CYH) strategic measures along with the surge in telehealth visits are likely to fetch revenues, which in turn, may bump up its share price.

Reasons to Add Acadia Healthcare (ACHC) to Your Portfolio

by Zacks Equity Research

Better-than-expected Q3 results, positive estimate revisions, high demand for services, bed expansion, business streamlining make Acadia Healthcare (ACHC) an attractive investment bet.

Sanghamitra Saha headshot

4 Sector ETFs & Stocks to Buy on Forecast-Beating Jobs Data

by Sanghamitra Saha

The U.S. economy added 638,000 jobs in October 2020, easing from an upwardly revised 672,000 in the previous month.

Sanghamitra Saha headshot

Wining & Losing Sector ETFs Post Election Day

by Sanghamitra Saha

Chances of a dividend congress caused a superb rally in Wall Street the day after election.

Humana's (HUM) Q3 Earnings Surpass Estimates, Decline Y/Y

by Zacks Equity Research

Humana's (HUM) third-quarter earnings reflect improved revenues, partly offset by expenses.

Select Medical's (SEM) Q3 Earnings Beat Mark, Improve Y/Y

by Zacks Equity Research

Select Medical's (SEM) third-quarter 2020 earnings gain traction from better revenues at its Critical Illness Recovery and Rehabilitation Hospital segments.

Universal Health's (UHS) Q3 Earnings Surpass, Improve Y/Y

by Zacks Equity Research

Universal Health's (UHS) third-quarter results reflect higher revenues and lower expenses.

Ensign Group's (ENSG) Q3 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

Ensign Group's (ENSG) Q3 results reflect healthy revenues and its robust Transitional and Skilled Services segment.

Molina Healthcare's (MOH) Q3 Earnings Beat, Increase Y/Y

by Zacks Equity Research

Molina Healthcare's (MOH) third-quarter results reflect higher revenues and membership.

Community Health's (CYH) Earnings Beat in Q3, Improve Y/Y

by Zacks Equity Research

Community Health's (CYH) third-quarter earnings gain from lower costs. However, the same is offset to some extent due to soft admissions.

Anthem (ANTM) Q3 Earnings Surpass Estimates, Decline Y/Y

by Zacks Equity Research

Anthem's (ANTM) Q3 earnings benefit from strong Medicaid and Medicare businesses as well as solid contributions from its Commercial & Specialty Business and Government Business.

Company News for Oct 27, 2020

by Zacks Equity Research

Companies In The News Are: HCA, SAP, NRZ, CBU.

HCA Healthcare (HCA) Q3 Earnings Miss Estimates, Down Y/Y

by Zacks Equity Research

HCA Healthcare's (HCA) third-quarter results reflect decline in admissions, partly offset by higher revenues.

HCA Holdings (HCA) Q3 Earnings Lag Estimates

by Zacks Equity Research

HCA (HCA) delivered earnings and revenue surprises of -28.62% and 0.04%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

HCA Healthcare (HCA) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

HCA Healthcare's (HCA) third-quarter 2020 results are likely to reflect higher revenues owing to the gradual rise in patient volumes following the easing of government restrictions.

Here's Why You Should Retain Universal Health (UHS) for Now

by Zacks Equity Research

Riding high on its solvency position, strong segments and strategic initiatives, Universal Health (UHS) holds potential to reap benefits.

Here's Why You Should Retain Tenet Healthcare (THC) Stock

by Zacks Equity Research

Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

David Borun headshot

A Volatile Week Ends with Stocks Broadly Higher

by David Borun

Stimulus talks grind on, but equity investors seem to be pricing in a big package.

HCA Healthcare (HCA) Announces Preliminary Results for Q3

by Zacks Equity Research

HCA Healthcare (HCA) reports preliminary results for the third quarter of 2020. Final results will be released on or around Oct 26.

Here's Why You Should Stay Away From HCA Healthcare Now

by Zacks Equity Research

HCA Healthcare (HCA) business is persistently hurt by the adverse coronavirus impact, which makes it an unattractive bet.

HCA Healthcare, EVERFI's Course to Enhance Behavioral Health

by Zacks Equity Research

HCA Healthcare (HCA) forms alliance with EVERFI, which provides middle and high school students with a digital course to address mental health disorders.

Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC

by Zacks Equity Research

Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC

Sapna Bagaria headshot

4 Hospital Stocks to Gain from Improving Admissions, Federal Aid

by Sapna Bagaria

Federal relief, higher admissions and cost containment are likely to aid the Zacks Medical-Hospital industry. HCA, UHS, CYH and THC are well-positioned to gain from a revival in admissions.

Here's Why Investors Should Bet on Ensign Group Stock Now

by Zacks Equity Research

Ensign Group (ENSG) remains well-poised for growth on the back of improving revenues, strategic buyouts and sound capital position.

Debanjana Dey headshot

3 Stocks to Buy From Strong MedTech Spaces Amid the Pandemic

by Debanjana Dey

Here are three stocks from three sub-sectors from MedTech that have held their ground despite the pandemic-led market mayhem.